An update on the pathological classification of breast cancer. Issue 1 (8th December 2022)

• Record Type: Journal Article
• Authors: Rakha, Emad A; Tse, Gary M; Quinn, Cecily M
• Other Names: Tse Gary M guestEditor.; Tan Puay Hoon guestEditor.; Rakha Emad A guestEditor.
• Is Part Of: Histopathology. Volume 82:Issue 1(2023)
• Page Start: 5
• Page End: 16
• Publication Date: 2022-12-08
• Subjects: breast cancer -- classification -- clinical -- differentiation -- grade -- molecular -- outcome -- stage; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.14786
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Breast cancer (BC) is a heterogeneous disease, encompassing a diverse spectrum of tumours with varying morphological, biological, and clinical phenotypes. Although tumours may show phenotypic overlap, they often display different biological behaviour and response to therapy. Advances in high‐throughput molecular techniques and bioinformatics have contributed to improved understanding of BC biology and refinement of molecular taxonomy with the identification of specific molecular subclasses. Although the traditional pathological morphological classification of BC is of paramount importance and provides diagnostic and prognostic information, current interest focusses on the use of a single gene and multigene assays to stratify BC into distinct groups to guide decisions on systemic therapy. This review considers approaches to the classification of BC, including their limitations, and with particular emphasis on the fundamental role of morphology in establishing an accurate diagnosis of primary invasive carcinoma of breast origin. This forms the basis for further morphological characterization and for all other approaches to BC classification that are used to provide prognostic and therapeutic predictive information. Abstract :